A new type of blood test may help physicians identify which patients with and without evidence of coronary blockages are at risk for heart attacks and strokes. Even individuals with normal levels of low-density lipoprotein (LDL), known as the so-called “bad” cholesterol, but still at risk, seem to be identified.
Mayo Clinic physicians, genetic counselors, and allied health staff are in San Diego for the WORLDSymposium, which presents the latest information from basic science, translational research, and clinical trials for lysosomal diseases. If you are at the meeting, visit us at booth #23.
The U.S. Food and Drug Administration recently updated its electronic filing requirements for importing goods, including biological specimens. Full enforcement of the new requirements will begin on Thursday, February 9, at 6 a.m. EST.